Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eiber

Showing results (71-80 of 376) with videos related to

Pageof 38
Sort By:
Medicine|April 21, 2023
Diagnostic significance of MRI versus CT using identical PET data in patients with recurrent differentiated thyroid cancer: A PET/MRI studyKorbinian Westphal, Matthias Eiber, Martin Henninger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 14, 2017
Prospective head-to-head comparison of <sup>11</sup>C-choline-PET/MR and <sup>11</sup>C-choline-PET/CT for restaging of biochemical recurrent prostate cancerMatthias Eiber, Isabel Rauscher, Michael Souvatzoglou, et al.
Scientific Reports|December 29, 2019
The effect of ligand amount, affinity and internalization on PSMA-targeted imaging and therapy: A simulation study using a PBPK modelNusrat J Begum, Gerhard Glatting, Hans-Jürgen Wester, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate CancerStephanie Robu, Margret Schottelius, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2023
Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?Benedikt Feuerecker, Clemens Kratochwil, Hojjat Ahmadzadehfar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 17, 2015
Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot studyIngo Einspieler, Klaus Thürmel, Thomas Pyka, et al.
Clinical Genitourinary Cancer|June 20, 2016
PSMA Theranostics Using PET and Subsequent Radioguided Surgery in Recurrent Prostate CancerTobias Maurer, Kristina Schwamborn, Margret Schottelius, et al.
Clinical Genitourinary Cancer|June 3, 2018
Gallium-68 HBED-CC-PSMA Positron Emission Tomography/Magnetic Resonance Imaging for Prostate Fusion BiopsyKay M Westenfelder, Beatrice Lentes, Julia Rackerseder, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2020
Almost 10 years of PET/MR attenuation correction: the effect on lesion quantification with PSMA: clinical evaluation on 200 prostate cancer patientsBorjana Bogdanovic, Andrei Gafita, Sylvia Schachoff, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2018
Pitfalls in Ga-68-PSMA-PET/CT: incidental finding of parathyroid adenomaChristian H Pfob, Ilham Karimov, Moritz Jesinghaus, et al.
Pageof 38

Showing results (71-80 of 376) with videos related to

Sort By:
Pageof 38
Medicine|April 21, 2023
Diagnostic significance of MRI versus CT using identical PET data in patients with recurrent differentiated thyroid cancer: A PET/MRI studyKorbinian Westphal, Matthias Eiber, Martin Henninger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 14, 2017
Prospective head-to-head comparison of <sup>11</sup>C-choline-PET/MR and <sup>11</sup>C-choline-PET/CT for restaging of biochemical recurrent prostate cancerMatthias Eiber, Isabel Rauscher, Michael Souvatzoglou, et al.
Scientific Reports|December 29, 2019
The effect of ligand amount, affinity and internalization on PSMA-targeted imaging and therapy: A simulation study using a PBPK modelNusrat J Begum, Gerhard Glatting, Hans-Jürgen Wester, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate CancerStephanie Robu, Margret Schottelius, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2023
Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?Benedikt Feuerecker, Clemens Kratochwil, Hojjat Ahmadzadehfar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 17, 2015
Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot studyIngo Einspieler, Klaus Thürmel, Thomas Pyka, et al.
Clinical Genitourinary Cancer|June 20, 2016
PSMA Theranostics Using PET and Subsequent Radioguided Surgery in Recurrent Prostate CancerTobias Maurer, Kristina Schwamborn, Margret Schottelius, et al.
Clinical Genitourinary Cancer|June 3, 2018
Gallium-68 HBED-CC-PSMA Positron Emission Tomography/Magnetic Resonance Imaging for Prostate Fusion BiopsyKay M Westenfelder, Beatrice Lentes, Julia Rackerseder, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2020
Almost 10 years of PET/MR attenuation correction: the effect on lesion quantification with PSMA: clinical evaluation on 200 prostate cancer patientsBorjana Bogdanovic, Andrei Gafita, Sylvia Schachoff, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2018
Pitfalls in Ga-68-PSMA-PET/CT: incidental finding of parathyroid adenomaChristian H Pfob, Ilham Karimov, Moritz Jesinghaus, et al.
Pageof 38